Inborn errors of Immunity and predisposition to infection by SARS-Cov-2 and the severity of COVID-19. International coordinated action. Full exomic sequencing. (project 1)
- Funded by National Institute of Health Carlos III [El Instituto de Salud Carlos III] (ISCIII)
- Total publications:2 publications
Grant number: COV20_01333
Grant search
Key facts
Disease
COVID-19Funder
National Institute of Health Carlos III [El Instituto de Salud Carlos III] (ISCIII)Principal Investigator
Rebeca Pérez de DiegoResearch Location
SpainLead Research Institution
FUNDACIÓN INVESTIGACIÓN BIOMÉDICA HOSPITAL LA PAZResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Immunity
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Adults (18 and older)
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
SARS-Cov-2 infection is mild or even asymptomatic in many patients, but it can cause severe illness (COVID-19), mainly in patients older than 50 years, especially those with comorbidities. There are, however, young patients without risk factors with severe forms of the disease. Some of these patients may have inborn errors of immunity (diseases often with incomplete penetrance). The main objective is the sequencing of the complete exome, using massive sequencing techniques, in patients under 50 years of age in the Spanish territory without comorbidities or risk factors. The project is part of an international consortium, of which we are one of the participating groups (https://www.cvidhge.com), in which information will be shared to carry out population studies that allow progress towards precision medicine in patients with COVID-19.
Publicationslinked via Europe PMC
Last Updated:an hour ago
View all publications at Europe PMC